I can tell you that VDPHL01 has a unique profile unlike current FDA-approved treatments, which are associated with cardiac ...

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

samantha busch shows off incredible hair growth after battling alopecia areata, revealing resilience, treatments, and a ...

Key Takeaways Spironolactone is effective for both premenopausal and postmenopausal women Finasteride is primarily used for ...

With Northway Biotech's expertise in biologics manufacturing, Mallia aims to enter the multi-billion-dollar alopecia market ...

Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

ERLANGEN, GERMANY AND VILNIUS, LITHUANIA - Mallia Therapeutics, a German biopharmaceutical company, and Northway Biotech, a ...

Alopecia areata is a chronic autoimmune disorder causing non-scarring hair loss due to immune system ... adherence through 24 weeks is crucial for treatment durability and success.

A dermatologist is a medical doctor who specializes in treating the skin, hair, and nails. Dermatologists care for people of all ages. Hair can play a big role in a person’s identity or culture, so ...

The goal is to find a cure for alopecia areata, an autoimmune disease that causes hair loss in distinct round patches.

Dermaliq Therapeutics, Inc. (Dermaliq) today announces that Ralf Paus, M.D., D.Sc., F.R.S.B. has joined the company’s Scientific and Medical Advisory Board.

Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...